Empagliflozin has been shown to significantly prevent the impairment of cognitive function in T2D db/db mice due to its ability to attenuate cerebral oxidative stress, as well as increase cerebral Brain-Derived Neurotrophic Factor (BDNF) levels [50]. This evidence concerns the gene BDNF and type 2 diabetes mellitus.